Andrea R. Teufelberger

Dr. Andrea R. Teufelberger

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SSSebastian Stentzel
Sebastian Stentzel
ATAndrea R. Teufelberger
Andrea R. Teufelberger
MNMaria Nordengrün
Maria Nordengrün
JKJulia Kolata
Julia Kolata
FSFrank Schmidt
Frank Schmidt
BBBarbara Bröker
Barbara Bröker
A substantial subgroup of asthmatic patients have "nonallergic" or idiopathic asthma, which often takes a severe course and is difficult to treat. The cause might be allergic reactions to the gram-positive pathogen Staphylococcus aureus, a frequent colonizer of the upper airways. However, the driving allergens of S aureus have remained elusive. We sought to search for potentially allergenic S aureus proteins and characterize the immune response directed against them. S aureus extracellular proteins targeted by human serum IgG4 were identified by means of immunoblotting to screen for potential bacterial allergens. Candidate antigens were expressed as recombinant proteins and used to analyze the established cellular and humoral immune responses in healthy adults and asthmatic patients. The ability to induce a type 2 immune response in vivo was tested in a mouse asthma model. We identified staphylococcal serine protease-like proteins (Spls) as dominant IgG4-binding S aureus proteins. SplA through SplF are extracellular proteases of unknown function expressed by S aureus in vivo. Spls elicited IgE antibody responses in most asthmatic patients. In healthy S aureus carriers and noncarriers, peripheral blood T cells elaborated TH2 cytokines after stimulation with Spls, as is typical for allergens. In contrast, TH1/TH17 cytokines, which dominated the response to S aureus α-hemolysin, were of low concentration or absent. In mice inhalation of SplD without adjuvant induced lung inflammation characterized by TH2 cytokines and eosinophil infiltration. We identify Spls as triggering allergens released by S aureus, opening prospects for diagnosis and causal therapy of asthma.

1 February 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
ATAndrea R. Teufelberger
Andrea R. Teufelberger
MNMaria Nordengrün
Maria Nordengrün
HBHarald Braun
Harald Braun
TMTania Maes
Tania Maes
KGKatrien De Grove
Katrien De Grove
Olga KryskoOlga Krysko
Olga Krysko

1 August 2019 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
ATAndrea R. Teufelberger
Andrea R. Teufelberger
BBBarbara M. Bröker
Barbara M. Bröker
Dmitri KryskoDmitri Krysko
Dmitri Krysko
CBClaus Bachert
Claus Bachert
Olga KryskoOlga Krysko
Olga Krysko

19 March 2019 in Allergy
Verified
Journal Article
Open access
PDF file
Olga KryskoOlga Krysko
Olga Krysko
ATAndrea R. Teufelberger
Andrea R. Teufelberger
SNSharon Van Nevel
Sharon Van Nevel
Dmitri KryskoDmitri Krysko
Dmitri Krysko
CBClaus Bachert
Claus Bachert
Staphylococcus aureus is being recognized as a major cofactor in atopic diseases such as atopic dermatitis, chronic rhinosinusitis with nasal polyps, and asthma. The understanding of the relationship between S aureus virulence factors and the immune system is continuously improving. Although the precise mechanism of the host's immune response adaptation to the variable secretion profile of S aureus strains continues to be a matter of debate, an increasing number of studies have reported on central effects of S aureus secretome in allergy. In this review, we discuss how colonization of S aureus modulates the innate and adaptive immune response, thereby predisposing the organism to allergic sensitization and disrupting immune tolerance in the airways of patients with asthma and chronic rhinosinusitis with nasal polyps. Next, we provide a critical overview of novel concepts dealing with S aureus in the initiation and persistence of chronic rhinosinusitis with nasal polyps and asthma. The role of the S aureus serine protease‐like proteins in the initiation of a type 2 response and the contribution of the IL‐33/ST2 signaling axis in allergic responses induced by bacterial allergens are discussed.

24 February 2015 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
DZDomen Zafred
Domen Zafred
BSBarbara Steiner
Barbara Steiner
ATAndrea R. Teufelberger
Andrea R. Teufelberger
AHAltijana Hromic
Altijana Hromic
PKP. Andrew Karplus
P. Andrew Karplus
PMPeter Macheroux
Peter Macheroux

30 August 2018 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
KGKatrien C. De Grove
Katrien C. De Grove
SPSharen Provoost
Sharen Provoost
HBHarald Braun
Harald Braun
EBEvy E. Blomme
Evy E. Blomme
ATAndrea R. Teufelberger
Andrea R. Teufelberger
TMTania Maes
Tania Maes